The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

Share Price Information for Marlowe (MRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 508.00
Bid: 506.00
Ask: 510.00
Change: 2.00 (0.40%)
Spread: 4.00 (0.791%)
Open: 508.00
High: 508.00
Low: 508.00
Prev. Close: 506.00
MRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

30 Oct 2015 07:00

RNS Number : 9402D
Marlowe Holdings Limited
30 October 2015
 

30 October 2015

 

Marlowe Holdings Limited ("Marlowe")

Half-Year Results 2015

 

Marlowe (AIM:MRL), the AIM listed cash shell, today issues its half-year results for the period to 30 September, 2015.

Summary:

 

· Placing of £5.2m completed in May to pursue investment opportunities; total cash currently available for acquisitions of £8.3m;

· Potential platform and bolt-on acquisition targets identified;

· Strategy fine-tuned to focus on annuity-type recurring asset maintenance services underpinned by the customer's obligation to meet stringent regulatory and legislative requirements;

· Acquisitions team strengthened by new appointments; attractive pipeline of investment opportunities;

· Half-year results show a broadly break-even performance (loss of £2k) for the 6 months to September.

 

Commenting on progress Alex Dacre, Chief Executive, said:

 

"Since the appointment of the new Board on 15 May 2015, and the completion of an oversubscribed share placing, we have been encouraged by the progress made in developing Marlowe's buy-and-build growth strategy.

 

During the period, we have identified attractive potential platform and bolt-on targets in line with our investment strategy. We believe that the targets identified could form the foundations of a dynamic B2B service group, focused on delivering essential annuity-type recurring asset maintenance services underpinned by the customer's obligation to meet stringent regulatory and legislative requirements. These requirements can result in a high level of forward revenue visibility. The targets occupy large, fragmented and operationally complex markets which we believe are poised for consolidation, offer attractive economies of scale and have growing barriers to entry. We look forward to executing our strategy and are confident that significant further progress will be made in the coming months.

 

Since May, as we have fine-tuned this strategy, we have made key appointments to the acquisitions team and have developed an attractive pipeline of investment opportunities. These represent the kind of deals that members of the Marlowe Board have a proven track record in completing. The markets that we are targeting offer significant scope for further growth through bolt-on acquisitions which can be executed at fair valuations and frequently fall below the radar of private equity or the large US owned multi-nationals who often occupy these types of markets. And, as a UK focused specialist with short lines of communication and the ability to move decisively and quickly, we believe we have a significant competitive advantage.

 

Finally, I'd like to take this opportunity to thank our shareholders for their continued support. I would only add that I and my fellow directors have, as a demonstration of our commitment to the success of your company, been working without remuneration since the Board's appointment. We look forward to updating shareholders of Marlowe's progress in due course."

 

Suspension of shares to trading on AIM

The Company notes the announcement made yesterday concerning the movement in share price and that it is contemplating a potential acquisition which would constitute a reverse takeover under the AIM Rules. As a result, trading in the Company's shares will be suspended until such time as an admission document is published in relation to the potential acquisition or the talks otherwise conclude. The Company will update shareholders with further information in due course. There can be no certainty that these discussions will lead to any transaction completing.

 

 

Enquires and further information:

 

 

Marlowe Holdings Limited

 

Alex Dacre, Chief Executive IR@marloweplc.com

 

Derek O'Neill, Group Finance Director +44 207 248 6700

 

 

Cenkos Securities

 

Nicholas Wells +44 207 397 8920

 

 

 

 

Summarised Income Statement (unaudited)

Six months ended September 30

 2015

 2014

 £000

 £000

Interest Income

65

48

Administrative expenses

(67)

(35)

Net profit/(loss) before and after taxation

(2)

13

 

Earnings per ordinary share (basic and diluted)

(0.02)

0.20

(in pence)

 

 

Summarised Balance Sheet

 30 September

 31 March

 2015

(unaudited)

 2015

(audited)

 £000

 £000

Fixed Assets

Property, plant and equipment

6

-

 

Current Assets

Cash and cash equivalents

8,293

3,156

Other receivables

21

26

Total assets

8,320

3,182

 

Current liabilities

 

Other payables

(10)

(21)

Net assets

8,310

3,161

 

 

Shareholders' equity

Share capital

7,292

3,000

Share premium

859

-

Retained earnings

159

161

Total shareholders' equity

8,310

3,161

 

 

 

Summarised Statement of Cash Flows (unaudited)

Six months ended September 30

2015

2014

 £000

 £000

Net cash generated from operating activities

(20)

39

Net cash generated from investing activities

6

-

Net cash generated from financing activities

5,151

-

Net increase in cash for the period

5,137

39

Cash at beginning of period

3,156

3,128

Cash at end of period

8,293

3,167

 

 

 

Statement of Changes in Shareholders' Equity

Called up share capital

Total shareholders' equity

Share premium

Retained earnings

 £000

 £000

 £000

 £000

Balance as at 1 April 2015

3,000

-

161

3,161

Net loss for the period

-

-

(2)

(2)

Placing of new shares during the period

4,292

859

-

5,151

Balance as at 30 September 2015

7,292

859

159

8,310

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR PGGWUUUPAGBB
Date   Source Headline
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20242:54 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
26th Mar 20244:45 pmRNSBlock listing Interim Review
18th Mar 20247:00 amRNSBoard Changes; Update re: Returns of Capital
26th Feb 20247:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
22nd Feb 20247:00 amRNSDisposal and Directorate Change
15th Jan 202410:23 amRNSChange of Nominated Adviser and Joint Broker
30th Nov 20237:00 amRNSTotal Voting Rights
28th Nov 20237:00 amRNSInterim results for the six months to 30 Sept 2023
23rd Nov 20237:00 amRNSNotice of Interim Results
31st Oct 20234:30 pmRNSTotal Voting Rights
27th Sep 20235:18 pmRNSHolding(s) in Company
26th Sep 20233:23 pmRNSBlock Admission
13th Sep 20236:15 pmRNSResult of AGM
13th Sep 20237:00 amRNSAnnual General Meeting and Trading Update
4th Sep 20237:00 amRNSHolding(s) in Company
8th Aug 20237:00 amRNSExercise of Share Options and Total Voting Rights
7th Aug 20237:45 amRNSResponse to Speculation
4th Aug 20233:50 pmRNSHolding(s) in Company
3rd Aug 20235:25 pmRNSHolding(s) in Company
31st Jul 20233:30 pmRNSIssue of Equity and Total Voting Rights
26th Jul 20237:00 amRNSAcquisition of IMSM
18th Jul 202312:15 pmRNSCapital Reduction Effective
13th Jul 20232:00 pmRNSPublication of Notice of AGM and Annual Report
29th Jun 20237:00 amRNSPreliminary results
26th Jun 20237:00 amRNSNotice of Full Year Results
23rd Jun 20234:56 pmRNSHolding(s) in Company
19th Jun 202311:06 amRNSResult of General Meeting
5th Jun 20239:31 amRNSHolding(s) in Company
2nd Jun 20232:51 pmRNSPosting of Circular and Notice of General Meeting
2nd Jun 202312:36 pmRNSHolding(s) in Company
18th Apr 20231:45 pmRNSHolding(s) in Company
29th Mar 20237:00 amRNSCapital Markets Day Replay
28th Mar 20237:00 amRNSCapital Markets Day and Trading Update
7th Mar 20237:00 amRNSNotice of Capital Markets Event
28th Feb 20232:20 pmRNSHolding(s) in Company
26th Jan 20231:46 pmRNSHolding(s) in Company
5th Jan 20237:00 amRNSNotice of Capital Markets Event
2nd Dec 20229:00 amRNSNotice of Investor Presentation
1st Dec 202210:34 amRNSDirector/PDMR Shareholding
1st Dec 20229:00 amRNSDirector/PDMR Shareholding
24th Nov 20222:14 pmRNSDirector/PDMR Shareholding
24th Nov 20221:48 pmRNSDirector/PDMR Shareholding
23rd Nov 20227:00 amRNSHalf-year Report
21st Nov 202212:54 pmRNSExercise of Share Options and Total Voting Rights
17th Nov 20227:00 amRNSNotice of Interim Results
2nd Nov 20225:08 pmRNSHolding(s) in Company
19th Oct 202210:40 amRNSExercise of Share Options and Total Voting Rights
14th Oct 20223:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.